Association of eGFR-related loci identified by GWAS with incident CKD and ESRD

PLoS Genetics

Volumn 7, Issue 9, 2011, Pages

  Böger, Carsten A ^a   Gorski, Mathias ^a,b   Li, Man ^c   Hoffmann, Michael M ^d   Huang, Chunmei ^e   Yang, Qiong ^f   Teumer, Alexander ^g   Krane, Vera ^h   O'Seaghdha, Conall M ^i,j   Kutalik, Zoltán ^k,l   Wichmann, H Erich ^b,m,n   Haak, Thomas ^o   Boes, Eva ^p   Coassin, Stefan ^p   Coresh, Josef ^q   Kollerits, Barbara ^p   Haun, Margot ^p   Paulweber, Bernhard ^r   Köttgen, Anna ^c,d   Li, Guo ^s   Shlipak, Michael G ^t,u   Powe, Neil ^u   Hwang, Shih Jen ^j   Dehghan, Abbas ^v,w   Rivadeneira, Fernando ^v,w   Uitterlinden, André ^v,w   Hofman, Albert ^v,w   Beckmann, Jacques S ^x   Krämer, Bernhard K ^y   Witteman, Jacqueline ^v,w   Bochud, Murielle ^z   Siscovick, David ^aa   Rettig, Rainer ^g   Kronenberg, Florian ^p   Wanner, Christoph ^h   Thadhani, Ravi I ^e   Heid, Iris M ^a,b   Fox, Caroline S ^i,j   Kao, W H ^q   more..

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF GREIFSWALD   (Germany)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j FRAMINGHAM HEART STUDY   (United States)

^k UNIVERSITY OF LAUSANNE   (Switzerland)

^l SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^o Diabetes Klinik Bad Mergentheim   (Germany)

^p INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^q JOHNS HOPKINS UNIVERSITY   (United States)

^r PARACELSUS MEDICAL UNIVERSITY   (Austria)

^s UNIVERSITY OF WASHINGTON   (United States)

^t VETERANS AFFAIRS MEDICAL CENTER   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v ERASMUS MEDICAL CENTER   (Netherlands)

^w Netherlands Genomics Initiative   (Netherlands)

^x LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^y UNIVERSITY OF HEIDELBERG   (Germany)

^z UNIVERSITY OF LAUSANNE   (Switzerland)

^aa UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALMS1 GENE; ANXA9 GENE; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; DAB2 GENE; DACH1 GENE; DISEASE COURSE; GCKR GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; NAT8 GENE; PRKAG2 GENE; SHROOM3 GENE; SLC34A1 GENE; STC1 GENE; UBE2Q2 GENE; UMOD GENE; ADULT; AGED; BLOOD; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; FEMALE; FOLLOW UP; GENETICS; KIDNEY DISEASE; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

CREATININE; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; GCKR PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAMM HORSFALL GLYCOPROTEIN; UMOD PROTEIN, HUMAN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CHRONIC DISEASE; CREATININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; UROMODULIN;

EID: 80053457834     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002292     Document Type: Article

References (53)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, et al. (2007) Chronic kidney disease as a global public health problem: approaches and initiatives- a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72: 247-59.
2. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-81.
3. Baumeister SE, Böger CA, Krämer BK, Doring A, Eheberg D, et al. (2010) Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population. Am J Nephrol 31: 222-9.
4. Meguid El Nahas A, Bello AK, (2005) Chronic kidney disease: the global challenge. Lancet 365: 331-40.
5. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225-32.
6. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C, (2005) Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165: 923-8.
7. Kastarinen M, Juutilainen A, Kastarinen H, Salomaa V, Karhapaa P, et al. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med 267: 612-20.
8. Ritz E, Stefanski A, (1996) Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27: 167-94.
9. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-47.
10. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, et al. (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-50.
11. Fox CS, Muntner P, (2008) Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988-1994 to 1999-2004. Diabetes Care 31: 1337-42.
12. Satko SG, Sedor JR, Iyengar SK, Freedman BI, (2007) Familial clustering of chronic kidney disease. Semin Dial 20: 229-36.
13. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-5.
14. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-92.
15. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-84.
16. Köttgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, et al. (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712-7.
17. Köttgen A, Pattaro C, Böger CA, Fuchsberger C, Olden M, et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-84.
18. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, et al. (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42: 373-5.
19. Ma RC, Tam CH, Wang Y, Luk AO, Hu C, et al. (2010) Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. JAMA 304: 881-9.
20. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, et al. (2005) Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54: 1171-8.
21. Pezzolesi MG, Katavetin P, Kure M, Poznik GD, Skupien J, et al. (2009) Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 58: 2698-702.
22. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, et al. (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58: 1403-10.
23. Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, et al. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus. Diabetologia 53: 2562-8.
24. Freedman BI, Bostrom M, Daeihagh P, Bowden DW, (2007) Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2: 1306-16.
25. He B, Osterholm AM, Hoverfalt A, Forsblom C, Hjorleifsdottir EE, et al. (2009) Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus. Am J Hum Genet 84: 5-13.
26. Zhang D, Efendic S, Brismar K, Gu HF Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus. BMC Med Genet 11: 116.
27. Köttgen A, Hwang SJ, Rampersaud E, Coresh J, North KE, et al. (2008) TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol 19: 1989-99.
28. Liu M, Shi S, Senthilnathan S, Yu J, Wu E, et al. (2010) Genetic variation of DKK3 may modify renal disease severity in ADPKD. J Am Soc Nephrol 21: 1510-20.
29. Wheeler HE, Metter EJ, Tanaka T, Absher D, Higgins J, et al. (2009) Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging. PLoS Genet 5: e1000685 doi:10.1371/journal.pgen.1000685.
30. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, et al. (1997) Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 278: 2069-74.
31. (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
32. Bash LD, Astor BC, Coresh J, (2010) Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 55: 31-41.
33. Kronenberg F, (2009) Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 5: 677-89.
34. Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, et al. (2001) Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions. Am J Pathol 159: 547-60.
35. Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, et al. (2010) Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 120: 4065-76.
36. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, et al. (2006) Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003.
37. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, et al. (2010) Rate of Kidney Function Decline Associates with Mortality. J Am Soc Nephrol 21: 1961-9.
38. Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, et al. (2011) Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death. J Gen Intern Med 26: 379-85.
39. Agarwal R, Bunaye Z, Bekele DM, Light RP, (2008) Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol 28: 569-75.
40. Borthwick E, Ferguson A, Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 341: c3365.
41. Kelly KJ, Dominguez JH, Rapid Progression of Diabetic Nephropathy Is Linked to Inflammation and Episodes of Acute Renal Failure. Am J Nephrol 32: 469-75.
42. van Kuijk JP, Flu WJ, Chonchol M, Hoeks SE, Winkel TA, et al. (2010) Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin J Am Soc Nephrol 5: 1198-204.
43. James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 78: 803-9.
44. Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, et al. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165: 54-67.
45. Winkelmayer WC, Owen WF Jr, Levin R, Avorn J, (2003) A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 14: 486-92.
46. Ward MM, (2009) Access to care and the incidence of end-stage renal disease due to diabetes. Diabetes Care 32: 1032-6.
47. Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS, Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 17: 254-64.
48. Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, et al. (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372: 547-53.
49. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-54.
50. Willer CJ, Li Y, Abecasis GR, METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190-1.
51. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-88.
52. Gauderman WJ, (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21: 35-50.
53. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-9.